Gefitinib Sandoz

Gefitinib Sandoz is an oral medication used to treat certain types of cancer. This pharmaceutical is designed to target specific proteins in cancer cells, potentially slowing their growth.

Gefitinib Sandoz is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has spread or cannot be removed by surgery. It works by targeting specific proteins in cancer cells, which may help to slow the growth and spread of the cancer. This medication is often prescribed when the cancer has a specific genetic marker, such as EGFR mutations.

Common effects of Gefitinib Sandoz may include skin rash, diarrhea, and dry skin. Some users may also experience nausea, vomiting, or appetite loss. These effects can vary in severity and may not affect everyone who takes the medication.

Gefitinib Sandoz should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication may not be suitable for everyone, especially those with certain medical conditions or allergies.

Gefitinib Sandoz may interact with other medications, including certain antibiotics, antifungals, and seizure medications. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, grapefruit and grapefruit juice should be avoided while taking this medication.